Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005)

Phase 2CompletedNCT00533650

Merck Sharp & Dohme LLC227 enrolled

Overview

A study to asses the safety and efficacy of MK0429 in postmenopausal women with osteoporosis.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

227

Conditions

Post-Menopausal Osteoporosis

Interventions

MK0429DRUG

Eligibility

Sex: FEMALEMin age: 50 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Person is a women with osteoporosis who is unwilling or unable to take other treatments for osteoporosis Exclusion Criteria: * Person has had a previous fracture * Person has rheumatoid arthritis. Person has has certain types of cancer * Person has donated blood or has been in another investigational study within the last 4 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.